Ventricular fibrillation in a left ventricular assist device patient: Can the echocardiogram be misleading?


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
03 2021
Historique:
received: 14 10 2020
revised: 08 12 2020
accepted: 14 01 2021
pubmed: 24 1 2021
medline: 10 8 2021
entrez: 23 1 2021
Statut: ppublish

Résumé

Sustained ventricular tachycardia and ventricular fibrillation (VF) are life-threatening arrhythmias which remain highly prevalent in patients with advanced heart failure. These ventricular arrhythmias may impair the support provided by continuous-flow left ventricular assist devices (CF-LVADs) and lead to frequent hospitalizations, antiarrhythmic medication use, external defibrillations, and need for heart transplantation. We report a case in which a patient with a CF-LVAD and an implantable cardioverter defibrillator at end of life presented with asymptomatic low-flow alarms and was found to have VF of unknown duration. Unique in our case was the presence of apparent organized contractility and rhythmic opening of the mitral valve on echocardiogram despite VF on electrocardiogram.

Identifiants

pubmed: 33484203
doi: 10.1111/jce.14904
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

862-866

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2251-2251.e2251.
Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart trans-plantation. N Engl J Med 2007;357:885-896.
Aaronson KD, Slaughter MS, Miller LW, et al.: Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012;125:3191-3200.
McIlvennan CK, Magid KH, Ambardekar AV, Thompson JS, Matlock DD, Allen LA Clinical outcomes after continuous-flow left ventricular assist device: a systematic review. Circ Heart Fail 2014;7:1003-1013.
Rogers JG, Aaronson KD, Boyle AJ, et al. Continuous flow left ventricular assist device improves functional ca-pacity and quality of life of advanced heart failure patients. J Am Coll Cardiol. 2010;55:1826-1834.
Ahmed A, Amin M, Boilson BA, Killu AM, Madhavan M Ventricular arrhythmias in patients with left ventricular assist device (LVAD). Curr Treat Options Cardio Med. 2019;21(11):75.
Saxon LA, Bristow MR, Boehmer J, et al. Predictors of sudden cardiac death and appropriate shock in the comparison of medical therapy pacing, and defibrillation in heart failure (COMPANION) trial, Circulation 2006;114:2766-2772.
Prinzing A, Herold U, Berkefeld A, Krane M, Lange R, Voss B. Left ventricular assist devices-current state and perspectives. J Thorac Dis. 2016;8(8):E660-E666. https://doi.org/10.21037/jtd.2016.07.13
Kilic A, Acker MA, Atluri P. Dealing with surgical left ventricular assist device complications. J Thorac Dis. 2015;7(12):2158-2164. https://doi.org/10.3978/j.issn.2072-1439.2015.10.64
Bujo C, Amiya E, Hatano M, et al. Clinical impact of newly developed atrial fibrillation complicated with longstanding ventricular fibrillation during left ventricular assist device support: a case report. BMC Cardiovasc Disord. 2019;19(1):151. https://doi.org/10.1186/s12872-019-1132-1
Patel P, Williams JG, Brice JH. Sustained ventricular fibrillation in an alert patient: preserved hemodynamics with a left ventricular assist device. Prehospital Emerg Care J, 15(4):533-536.
Busch MC, Haap M, Kristen A, Haas CS. Asymptomatic sustained ventricular fibrillation in a patient with left ventricular assist device. Ann Emerg Med 2011;57(1):25-28
Yap SC, Ramjankhan F, Muslem R, et al. Ventricular arrhythmias in patients with a continuous-flow left ventricular assist device. J Am Coll Cardiol. 2016;68(3):323-325.
Raasch. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. Am Heart J. 2012;164(3):373-378.
Salik JR, Thomas SS. Atrioventricular dissociation during ventricular fibrillation. N Engl J Med. 2020;382(23):e84. https://doi.org/10.1056/NEJMicm1916823
Gray RA, Pertsov AM, Jalife J. Spatial and temporal organization during cardiac fibrillation. Nature. 1998;392(6671):75-78. https://doi.org/10.1038/32164
Kirsten et al. Organization of ventricular fibrillation in the human heart, https://doi.org/10.1161/CIRCRESAHA.107.150730Circulation Research 2007;100:e87-e101
Baldwin ACW, Gemmato CJ, Sandoval E, Cohn WE, Morgan JA, Frazier OH. Tolerance of sustained ventricular fibrillation during continuous-flow left ventricular assist device support. Tex Heart Inst J. 2017;44(5):357-360. https://doi.org/10.14503/THIJ-16-5879

Auteurs

Manavotam Singh (M)

Division of Cardiology, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, District of Columbia, USA.

Nitin Malik (N)

Division of Cardiology, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
Department of Medicine, Georgetown University School of Medicine, Washington, District of Columbia, USA.

Vijaywant Brar (V)

Division of Cardiology, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
Department of Medicine, Georgetown University School of Medicine, Washington, District of Columbia, USA.

Patrick T Bering (PT)

Division of Cardiology, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
Department of Medicine, Georgetown University School of Medicine, Washington, District of Columbia, USA.

Cyrus Hadadi (C)

Division of Cardiology, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, District of Columbia, USA.

Farooq H Sheikh (FH)

Division of Cardiology, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
Department of Medicine, Georgetown University School of Medicine, Washington, District of Columbia, USA.

Phillip H Lam (PH)

Division of Cardiology, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
Department of Medicine, Georgetown University School of Medicine, Washington, District of Columbia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH